Rinati Skin, LLC   Report issue

For profit Phase 1
Founded: Hawthorne California United States (2009)

Organization Overview

First Clinical Trial
2020
NCT04395716
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Rinati Skin, LLC

Active Ingredients

Drugs in Phase 1 Trials (1)

hydrogen peroxide (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Communicable Diseases (Phase 1)

Coronavirus Infections (Phase 1)

Infections (Phase 1)

Pneumonia (Phase 1)

Severe Acute Respiratory Syndrome (Phase 1)

Overview

  • Highest Phase: Phase 1
  • # of Trials: 1
  • # of Trial APIs: 1